PTE News and Press, PolarityTE Inc. From 07/25/19

SALT LAKE CITY , July 25, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will report its calendar second quarter 2019 financial results by press release on...

The big news last week was the Federal Open Market Committee (FOMC) statement on Wednesday, which removed the word "patient" and set the Fed up for potential 0.25% key interest rate cuts at its July and/or September FOMC meetings. Interestingly, the FOMC statement also acknowledged that there ...

SALT LAKE CITY , June 10, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today the final results from a pilot study on the use of its SkinTE™ product for har...

SALT LAKE CITY , June 3, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE) today announced that the Board of Directors has created the Office of the Chief Executive, consisting of a team of three senior executives who will focus and collaborate on commercialization, operational a...

PolarityTE Bull(ets) PolarityTE (PTE) is a two-year-old microcap biotech in the regenerative medicine field. Its platform shows incredible promise in its early commercial use. Its first product, already on the market, only needs to gain a small toehold in its addressable market of burn and...

SALT LAKE CITY , May 21, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that final data from a pilot study on the use of its SkinTE™ product for hard-to-tre...

PolarityTE, Inc. (PTE) Q1 2019 Results Earnings Conference Call May 10, 2019, 08:00 AM ET Company Participants Rich Haerle - Vice President, Investor Relations and Corporate Strategy Denver Lough - Chairman, Chief Executive Officer and Chief R&D Officer Richard Hague - Chief ...

SALT LAKE CITY , May 10, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today data from two pilot studies on the use of its SkinTE™ product both showing succ...

PolarityTE (NASDAQ: PTE ): Q1 GAAP EPS of -$1.18 misses by $0.13 . More news on: PolarityTE, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SALT LAKE CITY , May 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today reported financial results for the first calendar quarter of 2019.  PolarityTE will host a co...